# US 2010/0168055 A1 · Combination of monosaccharide with c-glycoside derivative and use thereof

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2010/0168055 A1
- Document ID: US20100168055A1
- Status: Published application
- Kind: A1
- Application number: 12/649,366
- Filed: 2009-12-30
- Published: 2010-07-01
- Earliest claimed: 2008-12-30
- Assignees: L'oreal
- Inventors: Julien LABOUREAU; Jean-Thierry Simonnet; Pascal Portes
- Web page: https://patentgrep.com/patent/US20100168055A1

## CPC

- A61K 8/60: Sugars; Derivatives thereof
- A61K 8/06: Emulsions
- A61K 8/062: {Oil-in-water emulsions}
- A61K 8/602: {Glycosides, e.g. rutin}
- A61P 17/18: Antioxidants, e.g. antiradicals (preparations for protection against sunlight A61Q17/00)
- A61Q 19/08: Anti-ageing preparations
- A61K 2800/592: Mixtures of compounds complementing their respective functions
- A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)
- A61P: SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61Q: SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS

## Abstract

Composition, especially a cosmetic and/or dermatological composition, containing, in a physiologically acceptable medium, at least one of mannose, and rhamnose and at least one additional compound chosen from C-glycosides and C-glycoside derivatives. Use of such a composition, and also a device containing it.

## Claims

### Claim 1

A composition comprising, in a physiologically acceptable medium, at least one monosaccharide chosen from mannose and rhamnose and at least one additional compound chosen from C-glycosides and C-glycoside derivatives.

### Claim 2 (depends on 1)

The composition according to claim 1, comprising at least one C-glycoside that corresponds to formula (I):
in which:
R represents:
a saturated C1-C20 or unsaturated C2-C20 linear alkyl radical, or a saturated or unsaturated, branched or cyclic C3-C20 alkyl radical;
a saturated C1-C20 or unsaturated C2-C20 linear, or saturated or unsaturated, branched or cyclic C3-C20 hydrofluoroalkyl or perfluoroalkyl radical; the hydrocarbon-based chain constituting said radicals optionally being interrupted with 1 or more heteroatoms chosen from:
oxygen,
sulfur,
nitrogen, and
silicon,
and optionally being substituted with at least one radical chosen from:
—OR4,
—SR4,
—NR4R5,
—COOR4,
—CONHR4,
—CN,
a halogen atom,
a C1-C6 hydrofluoroalkyl or perfluoroalkyl radical, and/or
a C3-C8 cycloalkyl radical,
with R4 and R5 representing, independently of each other, a hydrogen atom or a saturated C1-C30 or unsaturated C2-C30 linear, or a saturated or unsaturated, branched or cyclic C3-C30 alkyl, perfluoroalkyl or hydrofluoroalkyl radical; or a C6-C10 aryl radical,
X represents a radical chosen from:
with R1, R2 and R3 representing, independently of each other, a hydrogen atom or a radical R, with R as defined above, and R′1 represents a hydrogen atom, an —OH group or a radical R as defined above, R1 optionally also denoting a C6-C10 aryl radical;
S represents a monosaccharide or a polysaccharide comprising up to 20 sugar units, in pyranose and/or furanose form and of L and/or D series, said mono- or polysaccharide optionally being substituted with a mandatorily free hydroxyl group, and optionally one or more optionally protected amine function(s), and
the bond S—CH2—X represents a bond of C-anomeric nature, which may be α or β,
and the cosmetically acceptable salts thereof, solvates thereof including hydrates, and isomers thereof.

### Claim 3 (depends on 4)

A composition according to claim 4, in which S represents a monosaccharide chosen from D-glucose, D-xylose, L-fucose, D-galactose and D-maltose.

### Claim 4 (depends on 3)

A composition according to claim 3, in which X represents a group chosen from —CO—, —CH(OH)— and —CH(NH2.

### Claim 5 (depends on 4)

A composition according to claim 4, in which R denotes a linear C1-C4, optionally substituted with —OH, —COOH or —COOR″2, R″2 being a C1-C4 saturated alkyl radical.

### Claim 6 (depends on 1)

A composition according to claim 1, comprising at least one C-glycoside derivative chosen from C-[β]-D-xylopyranoside-n-propane-2-one, C-[α]-D-xylopyranoside-n-propane-2-one, C-[β]-D-xylopyranoside-2-hydroxypropane, C-[α]-D-xylopyranoside-2-hydroxypropane, 1-(C-[β]-D-fucopyranoside)propane-2-one, 1-(C-[α]-D-fucopyranoside)propane-2-one, 1-(C-[β]-L-fucopyranoside)propane-2-one, 1-(C-[α]-L-fucopyranoside)propane-2-one, 1-(C-[β]-D-fucopyranoside)-2-hydroxypropane, 1-(C-[α]-D-fucopyranoside)-2-hydroxypropane, 1-(C-[β]-L-fucopyranoside)-2-hydroxypropane, 1-(C-[α]-L-fucopyranoside)-2-hydroxypropane, 1-(C-[β]-D-glucopyranosyl)-2-hydroxylpropane, 1-(C-[α]-D-glucopyranosyl)-2-hydroxylpropane, 1-(C-[β]-D-galactopyranosyl)-2-hydroxylpropane, 1-(C-[α]-D-galactopyranosyl)-2-hydroxylpropane, 1-(C-[β]-D-fucofuranosyl)propane-2-one, 1-(C-[α]-D-fucofuranosyl)propane-2˜one, 1-(C-[β]-L-fucofuranosyl)propane-2-one, 1-(C-[α]-L-fucofuranosyl)propane-2-one, C-[β]-D-maltopyranoside-n-propane-2-one, C-[α]-D-maltopyranoside-n-propane-2-one, C-[β]-D-maltopyranoside-2-hydroxypropane, C-[α]-D-maltopyranoside-2-hydroxypropane, isomers thereof and mixtures thereof.

### Claim 7 (depends on 1)

A composition according claim 1, in which the amount of the monosaccharide(s) is 0.001%-30% by weight relative to the total weight of the composition.

### Claim 8 (depends on 1)

A composition according to claim 1, in which the amount of the said additional compound(s) is 0.001%-30% by weight relative to the total weight of the composition.

### Claim 9 (depends on 1)

A method comprising applying the composition of claim 1 to human skin and/or its integuments.

### Claim 10 (depends on 1)

A method for reducing and/or preventing the signs of aging of the skin or its integuments, improving the radiance of the complexion, for reducing and/or preventing the characteristics of wrinkles and/or fine lines, for improving and/or decreasing the microrelief of the skin, for making the skin smooth and/or for improving the mechanical properties of the skin and/or for increasing the resistance of the skin to mechanical attack, and/or for promoting skin repair comprising applying the composition of claim 1 to human skin in need thereof.

### Claim 11 (depends on 1)

A method for improving the density and firmness of the skin and/or the cohesion of its various compartments comprising applying the composition of claim 1 to human skin in need thereof.

### Claim 12 (depends on 1)

A method for preventively or curatively treating wrinkles and/or fine lines, withered skin, lack of skin elasticity and/or tonicity, thinning of the dermis, degradation of collagen fibres, flaccid skin, thinned skin and/or any internal degradation of the skin caused by exposure to ultraviolet radiation comprising applying the composition of claim 1 to human skin in need thereof.

### Claim 13 (depends on 1)

A method for stimulating the synthesis of glycosaminoglycans containing a D-glucosamine and/or N-acetyl-D-glucosamine residue, and/or proteoglycans, by the fibroblasts and/or keratinocytes comprising applying the composition of claim 1 to human skin in need thereof.

### Claim 14 (depends on 1)

A method for increasing the synthesis of laminins and the synthesis of collagens comprising applying the composition of claim 1 to human skin in need thereof.

### Claim 15

A device comprising at least a combination of at least one monosaccharide chosen from mannose and rhamnose and at least one additional compound chosen from C-glycosides and C-glycoside derivatives, the device being suitable for intraepidermal and/or intradermal and/or subcutaneous injection of said combination.
